Skip to content

Role of Caregiver in the Clinical Pathway of Patients With Breast and Prostate Cancer

The Role of Caregiver in the Clinical Pathway of Patients Newly Diagnosed With Breast and Prostate Cancer: a Randomized Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06468293
Enrollment
102
Registered
2024-06-21
Start date
2022-10-08
Completion date
2024-12-31
Last updated
2024-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

The following randomized longitudinal study will evaluate the long term impact of caregivers' involvement in cancer care pathway, including a psychological support intervention on the dyads to be delivered after the detection of a suspected cancer and before the visit with the oncologist for discussing therapeutic options.

Detailed description

The following randomized longitudinal study will evaluate the long term impact of caregivers' involvement in cancer care pathway, including a psychological support intervention on the dyads to be delivered after the detection of a suspected cancer and before the visit with the oncologist for discussing therapeutic options. Moreover, a battery of self-report questionnaires will be administered, and sociodemographic and clinical data will be collected. The time window in which to deliver the support intervention is after the detection of a suspected cancer and before the visit with the oncologist, at the time when the patient undergoes diagnostic exams (to understand the type of tumor he/she is affected by), and the most suitable therapeutic protocol have to be discussed with the oncologist.

Interventions

OTHERPsychological support

Psychological support intervention

Sponsors

European Institute of Oncology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patient: * Patient aged ≥18 years at the time of recruitment. * Patients who have just received a cancer diagnosis and have yet to discuss with their oncologist the treatment to undergo after diagnosis of breast or prostate cancer. * Early-stage cancer (I or II). Caregiver: * Age ≥ 18 at the time of recruitment. * Taking care of the patient.

Exclusion criteria

Patients: * Presence of early mental disorders (before age 40) or severe neurological disorder. * Patients with advanced stage cancer for which the path is already defined (palliative care patients). Caregivers: ● Presence of early mental disorders (before age 40) or severe neurological disorder.

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the compliance with therapy6 monthsThe primary endpoint of this study is to observe a difference of 3 points in the average values of the Interpersonal aspect of care and Subjective norm subscales of the Adherence Determination Questionnaire (ADQ), in favor of the intervention group. Response options for each item formed a 5-point Likert scale (1 = strongly disagree; 2 = disagree; 3 = neither agree nor disagree; 4 = agree; 5 = strongly agree). The ADQ questionnaire contains 38 questions, with items 15 and 17 through 24 specifically phrased for patients who have cancer

Countries

Italy

Contacts

Primary ContactGabriella Pravettoni
gabriella.pravettoni@ieo.it+390257489731

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026